VRTX News and Press, Vertex Pharmaceuticals Incorporated From 06/25/24

2024-06-25 09:00:00 ET Summary Catalent stock rose 3% after Elevidys label expansion approval by the FDA. Sarepta's stock reached an all-time high after Elevidys label expansion approval. Several companies including PFE, CAPR, RGNX, SLDB, VRTX, have DMD gene-therapy product candid...

2024-06-25 04:12:00 ET Vertex Pharmaceuticals (NASDAQ: VRTX) recently excited the medical community with clinical trial results from an experimental diabetes treatment it's developing. In a nutshell, it looks like a single infusion of VX-880 allowed a dozen diabetes patients to begi...

2024-06-24 08:15:04 ET Wells Fargo analyst issues OVERWEIGHT recommendation for VRTX on June 24, 2024 07:08AM ET. The previous analyst recommendation was Overweight. VRTX was trading at $468.71 at issue of the analyst recommendation. The overall analyst consensus : BUY. ...

2024-06-21 16:53:53 ET More on Vertex Pharmaceuticals Vertex: New, Longer-Term Casgevy Data Makes Case For Blockbuster Sales Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Vertex Pharmaceuticals Incorpor...

– All 12 patients who received the full dose of VX-880 as a single infusion demonstrated islet cell engraftment and glucose-responsive insulin production by Day 90 – – All patients achieved ADA-recommended target HbA1c levels <7.0% and >70% time-in-range (70-180...

2024-06-21 05:51:00 ET Nearly everything is going right these days for Eli Lilly (NYSE: LLY) . Sales and profits have been soaring. So has the share price, jumping more than 50% year to date after a 59% gain in 2023. Lilly now ranks as the biggest healthcare company in the world. Th...

2024-06-20 15:38:41 ET More on Vertex Pharmaceuticals Vertex: New, Longer-Term Casgevy Data Makes Case For Blockbuster Sales Vertex Pharmaceuticals Incorporated (VRTX) Goldman Sachs 45th Annual Global Healthcare Conference (Transcript) Vertex Pharmaceuticals Incorpor...

2024-06-18 06:50:00 ET Buying a stock with the intention of never selling it, or perhaps only selling it in a few decades, requires a level of conviction that most investments simply don't warrant. It's not enough to believe that a business is doing well today, or that its management team r...

2024-06-17 13:20:51 ET Summary Vertex Pharmaceuticals Incorporated is a $120bn market cap pharma giant with a successful CF franchise, growing revenues from $1bn in 2015 to $9.9bn in 2023. Vertex gained approval for its first non-CF drug, Casgevy, utilizing CRISPR technology to tr...

2024-06-17 11:00:06 ET Jasper Hellweg from Argus Research issued a price target of $550.00 for VRTX on 2024-06-17 08:57:00. The adjusted price target was set to $550.00. At the time of the announcement, VRTX was trading at $474.61. The overall price target consensus is a...